OGA and tauopathy: In a validated pre-clinical model of tauopathy, the designed OGA-inhibitor Thiamet-G [10,11] increased the O-GlcNAc-ylation of many proteins rapidly (hours) and stably (months) in wild-type and transgenic mouse brain.